نتایج جستجو برای: hyperphosphatemia

تعداد نتایج: 1216  

Journal: :P & T : a peer-reviewed journal for formulary management 2015
Adam Pennoyer Mary Barna Bridgeman

Ferric citrate (Auryxia) for the treatment of hyperphosphatemia.

Journal: :Journal of the American Society of Nephrology 2003

Journal: :Nihon Naika Gakkai Zasshi 2020

Journal: :Journal of Korean Academy of Fundamentals of Nursing 2023

Purpose: The purpose of this study was to investigate the status hyperphosphatemia in patients with chronic renal failure (CRF) and examine effects dialysis-related characteristics, nutritional status, self-care, stress, social support on hyperphosphatemia.Methods: This descriptive research designed identify factors influencing development diagnosed CRF. A convenience sample 150 receiving hemod...

2017
Cínthia Ribas Martorelli Márcia Mery Kogika Fernanda Chicharo Chacar Douglas Segalla Caragelasco Ana Carolina Brandão de Campos Fonseca Pinto Carla Aparecida Batista Lorigados Lúcia Conceição Andrade

The increase of urinary fractional excretion of phosphorus (uFEP) may indicate phosphorus retention before the onset of hyperphosphatemia in the early stages of chronic kidney disease (CKD). The hypothesis of this study is whether uFEP may increase during the early stage of CKD as a compensatory mechanism to prevent hyperphosphatemia as well as whether hyperphosphatemia in the late stages is as...

Journal: :Journal of the American Society of Nephrology : JASN 2008
Suresh Mathew Kimberly S Tustison Toshifumi Sugatani Lala R Chaudhary Leonard Rifas Keith A Hruska

Hyperphosphatemia and vascular calcification have emerged as cardiovascular risk factors among those with chronic kidney disease. This study examined the mechanism by which phosphorous stimulates vascular calcification, as well as how controlling hyperphosphatemia affects established calcification. In primary cultures of vascular smooth muscle cells derived from atherosclerotic human aortas, ac...

Journal: :Nephron. Physiology 2007
Vincenzo Savica Lorenzo A Calò Renato Caldarera Adelaide Cavaleri Antonio Granata Domenico Santoro Rodolfo Savica Ugo Muraca Agostino Mallamace Guido Bellinghieri

BACKGROUND/AIMS Hyperphosphatemia is recognized as contributing to the increased risk of cardiac death in end-stage renal disease (ESRD) and hemodialysis (HD) patients. Currently available pharmacologic treatment for hyperphosphatemia is based on phosphate binders but, despite treatment, only half of the patients fall within the range for serum phosphorus of the K/DOQI guidelines. Therefore, th...

Journal: :Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 2008
Keith A Hruska Suresh Mathew Richard Lund

Osteoporosis is a common complication of chronic kidney disease (CKD), and the latter is a major risk factor for cardiovascular mortality. Recent studies have elucidated some of the mechanisms by which CKD is a cardiovascular risk, and they relate to osteoporosis. Thus, the mechanisms of CKD induced cardiovascular risk provide valuable insight into the relationship between cardiovascular diseas...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید